Cantel Medical Corp.

Infection prevention device maker reports EPS of $0.23

Published in Health Risk Factor Week, January 3rd, 2006

Cantel Medical Corp. (CMN) reported net income of $3,746,000, an increase of 21%, or $0.23 per diluted share, on sales of $60,233,000, an increase of 33%, for its first quarter ended October 31, 2005, as compared with net income of $3,107,000, or $0.20 per diluted share, on sales of $45,342,000 for the quarter ended October 31, 2004.

Of the 33% increase in net sales, 4% was from the company's core businesses (6% without Carsen) and 29% was from Crosstex, which was acquired on August 1, 2005.

James P. Reilly, president and CEO of Cantel, commented, "The results for the quarter ended October 31, 2005 included approximately $683,000, net of tax, or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Risk Factor Week

Source: Health Risk Factor Week (2006-01-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry